Skip to main content
. Author manuscript; available in PMC: 2024 May 14.
Published in final edited form as: J Glob Antimicrob Resist. 2024 Jan 24;36:309–318. doi: 10.1016/j.jgar.2024.01.009

Table 1.

Campylobacter genomes selected for analysis of antimicrobial resistance genes and point mutations

Characteristic C. jejuni (N = 97)a C. coli (N = 67)
CIP resistant AZM resistant (n = 12) CIP resistant AZM susceptible (n = 56) CIP susceptible AZM susceptible (n = 28) CIP resistant AZM resistant (n = 28) CIP resistant AZM susceptible (n = 24) CIP susceptible AZM susceptible (n = 15)
Sex (n)
Female 6 32 13 15 19 7
Male 6 24 15 13 5 8
Type of Sample (n) Diarrhoea 3 25 15 5 6 2
Asymptomatic 9 31 13 23 18 13
Age (months)
Median 11.1 12.8 8.3 16.7 16.5 9.0
IQR 8.0–15.7 7.6–16.7 6.3–15.8 14.0–20.0 10.5–20.1 7.9–17.9
Min 3.1 1.0 2.1 0.4 4.8 2.6
Max 35.4 34.0 32.0 24.0 38.9 23.0

Selection for inclusion enriched to include isolates with phenotypic resistance upon antimicrobial resistance testing to the two first-line antimicrobials ciprofloxacin and azithromycin.

a

One isolate (n = 1) is classified as CIP susceptible and AZM resistant. It is from an asymptomatic faecal sample from a female participant.